New Huo Tech to Launch DeFi and Metaverse Thematic Investments

EQS Newswire / 28/12/2022 / 10:24 UTC+8 New Huo Tech to Launch DeFi and Metaverse Thematic Investments   【23rd December, 2022, Hong Kong】New Huo Technology Holdings Limited (“New Huo Tech”, Stock code 1611.HK) today is pleased to announce that its licensed compliance fund manager, New Huo Asset Management (Hong Kong) Limited (“NH Asset”), has partnered […]

CN Logistics and its eCommerce Platforms Honoured in the “Asia’s Best E-tailing Awards 2022”

EQS Newswire / 20/12/2022 / 08:00 UTC+8 [Hong Kong – 20 December 2022] A well-established international logistics solutions provider, CN Logistics International Holdings Limited (the “Company”, together with its subsidiaries, the “Group”, stock code: 2130), is delighted to announce that it is honoured as “Excellence of Innovation” in the “Asia’s Best E-tailing Awards 2022”, with […]

Hong Kong E-Commerce Logistics Association and Hong Kong General Chamber of Commerce Young Executives Club visit Logistics and Supply Chain MultiTech R&D Centre promoting supply chain transformation

EQS Newswire / 15/12/2022 / 09:00 UTC+8 Hong Kong E-Commerce Logistics Association and Hong Kong General Chamber of Commerce Young Executives Club visit Logistics and Supply Chain MultiTech R&D Centre promoting supply chain transformation   Connections and collaboration are the keys for innovation. As we approach the end of 2022, staying on top of the […]

Moderna and Merck Announce mRNA-4157/V940, Investigational Personalized mRNA Cancer Vaccine, in Combination With KEYTRUDA® (pembrolizumab), Met Primary Efficacy Endpoint in Phase 2b Trial

EQS Newswire / 13/12/2022 / 07:08 EST/EDT Moderna and Merck Announce mRNA-4157/V940, Investigational Personalized mRNA Cancer Vaccine, in Combination With KEYTRUDA® (pembrolizumab), Met Primary Efficacy Endpoint in Phase 2b Trial mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a statistically significant and clinically meaningful reduction in the risk of disease recurrence or death compared to KEYTRUDA monotherapy […]

GALA Sports’ Total Football takes mobile game entertainment to the next level to maximize the fun of World Cup Qatar 2022

EQS Newswire / 05/12/2022 / 17:27 UTC+8 GALA Sports’ Total Football takes mobile game entertainment to the next level to maximize the fun of World Cup Qatar 2022 Total Football, a genuine football simulation game for smartphones, launched just before the start of the World Cup 2022 to ride the momentum Innovative breakthroughs in AI, […]

Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826’s Treatment of Female Androgenetic Alopecia in China Was Met

EQS Newswire / 02/12/2022 / 10:34 UTC+8 Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826’s Treatment of Female Androgenetic Alopecia in China Was Met   Suzhou, December 1, 2022 – Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced […]

Hong Kong E-Commerce Logistics Association (HKELA) collaborates with Cyberport to Promote Digital Freight and Smart Logistics

EQS Newswire / 30/11/2022 / 09:00 UTC+8 Hong Kong E-Commerce Logistics Association (HKELA) collaborates with Cyberport to Promote Digital Freight and Smart Logistics The emergence of ecommerce transforms not only how businesses sell, but also how businesses ship. Driven by the increasing market competition and customer demand, traditional supply chains aren’t enough anymore. Companies need […]

Fast and Steady High-quality Development of the New Higher Education Group Delivers New Achievements Continuously with High-quality and Precision Investments

EQS Newswire / 29/11/2022 / 09:00 UTC+8   BUSINESS HIGHLIGHTS   The Group adheres to the concept of “Student-oriented” and continuously increases high-quality and precise investments, delivering fruitful achievements in high quality teaching, high quality employment and high quality students and teachers’ experience, and its high-quality development strategy has been steadily advanced. The education and […]

Chow Tai Fook Jewellery Group Announces FY2023 Interim Results

EQS Newswire / 24/11/2022 / 16:45 UTC+8   Chow Tai Fook Jewellery Group Announces FY2023 Interim Results Results Highlights Despite the macro-economic challenges and pandemic-led business disruptions, the Group reported a resilient set of results as revenue rose 5.3% year-on-year to HK$46,535 million for 1HFY2023, supported by favourable store opening momentum in Mainland China (the […]

Kintor Pharma announced completion of phase I trial of the world’s first PROTAC compound (GT20029) for topical use

EQS Newswire / 24/11/2022 / 09:48 UTC+8 Kintor Pharma announced completion of phase I trial of the world’s first PROTAC compound (GT20029) for topical use     Suzhou, November 24, 2022 – Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced the top-line results for its phase […]

China XLX’s Revenue for 9M 2022 Increased by 49% YoY Commissioning of various production bases in different regions drives the Group’s high-quality production development

EQS Newswire / 21/11/2022 / 19:03 UTC+8   China XLX’s Revenue for 9M 2022 Increased by 49% YoY Commissioning of various production bases in different regions drives the Group’s high-quality production development     Highlights of 2022 First Three Quarters Results: Revenue increased by 49% YoY to approximately RMB17,516 million. Net profit increased by 14% […]

MegaPro Biomedical MPB-1734 Receives Composition Patent for New Dosage Form of Anticancer Drug which enhanced the immune-combination therapy

EQS Newswire / 15/11/2022 / 10:41 UTC+8   MegaPro Biomedical (6827) Press Release on MegaPro Biomedical Receiving Compositional Patent for MPB-1734, an anti-cancer 505(b)(2) new formulation drug. Release Date: November 15, 2022   MegaPro Biomedical MPB-1734 Receives Composition Patent for New Dosage Form of Anticancer Drug which enhanced the immune-combination therapy   MegaPro Biomedical Co., […]

Apply the network operation and Scheduling system based on Multi-Operator BaaS Collaboration to manage the world’s largest 5G Co-Construction and Sharing network

EQS Newswire / 14/11/2022 / 15:00 UTC+8 Apply the network operation and Scheduling system based on Multi-Operator BaaS Collaboration to manage the world’s largest 5G Co-Construction and Sharing network     Unprecedented Challenges for China Unicom and China Telecom in building and operating the world’s largest shared 5G SA network have inspired innovations in many […]